bluuebunny/crossref_metadata_2025_split huggingface dataset:
Left atrial function after standalone totally thoracoscopic left atrial appendage exclusion in atrial fibrillation patients with absolute contraindication to oral anticoagulation therapy
Authors: Marini Massimiliano , Pannone Luigi , Branzoli Stefano , Tedoldi Francesca , D’Onghia Giovanni , Fanti Diego , Sarao Emanuele , Guarracini Fabrizio , Quintarelli Silvia , Monaco Cinzia , Graffigna Angelo , Bonmassari Roberto , La Meir Mark , Chierchia Gian Battista , de Asmundis Carlo 
Published: November 2022

BackgroundLeft atrial appendage (LAA) is a common source of thrombi in patients with atrial fibrillation (AF). The effect on left atrial (LA) function of the Totally Thoracoscopic (TT)-LAA exclusion with epicardial clip is currently unknown. This study aims at evaluating the effect of TT-LAA exclusion on LA function.MethodsStandalone TT-LAA exclusion with the clip device was performed in 26 patients with AF and contraindication to oral anticoagulation (OAC). A 3D CT scan, trans-esophageal echocardiography, spirometry and cerebrovascular doppler ultrasound were performed preoperatively. Clip positioning and LAA exclusion were guided and confirmed by intraoperative trans-esophageal echo. To evaluate LA function, standard transthoracic echocardiography and 2D strain of LA were performed before surgery, at discharge and at 3-month follow-up.ResultsThe mean CHA2DS2-VASc and HASBLED scores were 4.6 and 2.4 respectively. There were no major complications during the procedure. At median follow-up of 10.3 months, 1 (3.8%) non-cardiovascular death, 1 (3.8%) stroke and 4 (15.4%) cardiovascular hospitalizations occurred. At 2D strain of LA, the reservoir function decreased significantly at discharge, compared to baseline and recovered at 3-months follow-up. Furthermore, NT-proBNP increased significantly after the procedure with a return to baseline after 3 months. Changes in E/A were persistent at 3 months.ConclusionOur data in a small cohort suggest that TT-LAA exclusion with epicardial clip can be a safe procedure with regards to the atrial function. The LAA amputation impairs the reservoir LA function on the short term, that recovers over time.
Association and functional analysis of angiotensin-converting enzyme 2 genetic variants with the pathogenesis of pre-eclampsia
Authors: Huang Gongchen , Wang Yukun , Qin Linyuan , Huang Bo , Yu Xiangyuan 
Published: November 2022

ObjectiveThe aim of this study was to investigate the relationship between potential functional single-nucleotide polymorphisms (SNPs) of the angiotensin-converting enzyme 2 (ACE2) gene and the pathogenesis of pre-eclampsia (PE) in Guangxi, China.Materials and methodsA case–control study was conducted involving 327 PE cases and 591 age-matched, normal, singleton pregnant women. Potential functional ACE2 gene variants (rs2106809 A&gt;G, rs6632677 G&gt;C, and rs2074192 C&gt;T) were selected and genotyped using kompetitive allele-specific PCR. The strength of the associations between the studied genetic variants and the risk of PE were evaluated using odds ratios (ORs) and corresponding 95% confidence intervals (CIs).ResultAfter adjusting for age and body mass index (BMI), unconditional logistic regression analysis showed that rs2106809 A&gt;G was significantly associated with PE risk (AG vs. AA, OR = 1.43, 95% CI = 1.03–1.99, p = 0.034; AG/GG vs. AA, OR = 1.45, 95% CI = 1.06–1.99, p = 0.019), especially with severe PE (AG vs. AA, adjusted OR = 1.70, 95% CI = 1.10–2.61; AG/GG vs. AA, adjusted OR = 1.71, 95% CI = 1.14–2.57). Further stratified analysis showed that rs2106809 was even more pronounced in subjects in the pre-pregnancy BMI (pre-BMI) &gt;23 kg/m2 (adjusted OR = 2.14, 95% CI = 1.32–3.45) and triglyceride (TG) &gt;2.84 mmol/L subgroups (adjusted OR = 1.81, 95% CI = 1.09–3.01) under the dominant genetic model. We also found that rs2106809 interacted with pre-BMI (pinteraction = 0.040), thereby affecting an individual’s genetic susceptibility to PE. Multiple dimension reduction analysis demonstrated that rs2106809 made the best one-locus model, and the three-locus model was the best interaction model for predicting PE risk. Functional analysis suggested that rs2106809 A&gt;G causes a change in the reliability of classifications of two putative splice sites in the ACE2 gene, potentially regulating the expression of functional genes (PIR, ACE2, and CLTRN) in multiple tissues and cell lines (p&lt; 0.05).ConclusionThe ACE2 gene rs2106809 A&gt;G variant is significantly associated with the risk of PE via individual locus effects and/or complex gene–gene and gene–environment interactions. Regulating the expression of functional genes such as PIR, ACE2, and CLTRN may be the molecular mechanism by which rs2106809 increases an individual’s susceptibility to PE.
Screening and validation of lymph node metastasis risk-factor genes in papillary thyroid carcinoma
Authors: Zhang Qiaoyue , Li Jing , Shen Hengyan , Bai Xinyu , Zhang Tao , Liu Ping 
Published: November 2022

BackgroundAlthough most papillary thyroid carcinoma (PTC) cases have a good prognosis, some PTCs are more aggressive and are often accompanied by lymph node (LN) metastasis, a high recurrence rate, and poor prognosis. Distinguishing highly invasive metastatic PTC is an urgent problem that needs to be addressed clinically. We analyzed a microarray of metastasized PTC and validated it using quantitative reverse transcription PCR (RT-qPCR) and immunohistochemistry to identify biomarkers that can be used to assess the risk of PTC metastasis.MethodsThe microarray of metastasized PTC was screened using the Gene Expression Omnibus (GEO) database. The differences between cancer and normal tissues were analyzed using the official GEO tool: GEO2R. Gene expression profile data (GEPIA) were used to verify the expression of differential genes in large samples and to analyze their correlation. The Kaplan–Meier plotter (KM-plotter) database was used for the analysis of genes potentially related to survival. RT-qPCR was used to check the expression of risk factor genes in pathological sections from PTC patients with clinical LN metastasis. Immunohistochemistry was used to verify the expression of core risk-associated genes.ResultsFourteen PTC metastasis-associated genes were identified. In metastasized PTC, CLDN1, LRP4, LRRK2, and TENM1 were highly expressed, whereas DIO1, DPP6, HGD, IPCEF1, MT1F, SLC26A4, SLC26A7, SPX, TFF3, and TPO were expressed at low levels, compared to expression in normal tissues. DIO1, HGD, SLC26A4, and TPO were found to be the core risk genes in the PTC metastatic risk set. Results based on clinical samples showed that the expression differences for metastasis risk-associated genes were consistent with the bioinformatics analysis results.ConclusionsFourteen differentially expressed genes (CLDN1, LRP4, LRRK2, TENM1, DIO1, DPP6, HGD, IPCEF1, MT1F, SLC26A4, SLC26A7, SPX, TFF3, TPO) are associated with an increased risk of PTC metastasis, and DIO1, HGD, SLC26A4, and TPO are the key risk-associated genes in this set that might affect the occurrence and development of PTC through iodine metabolism. These genes could provide a reference for clinical metastatic PTC risk evaluation and treatment.
Elevation gradient shapes microbial carbon and phosphorous limitations in the Helan Mountains, Northwest China
Authors: Wu Mengyao , Liu Zhen , Chen Lin , Pang Danbo , Xu Xuelei , Zhang Yaqi , Ni Xilu , Hu Yang , Li Xuebin 
Published: November 2022

Soil extracellular ecoenzymatic activities (EEA) are major players in the biogeochemical cycles and are closely related to the metabolic demand and nutrient supply in microbes. However, their effects on biogeochemistry along the elevation gradient on mountain ecosystems in arid regions remain unclear. To address this, we investigated the variations of soil microbial resource limitation and the relative contributing factors along the elevation gradient of the Helan Mountains, northwest China. The results showed that the relative abundance of total microbial, bacterial, fungal, actinomycetes, and N-acquiring enzymatic activities (N-Acetyl-β-D-glucosaminidase and Leucine- α-aminopeptidase, that are NAG and LAP, respectively) in the soil first increased and then decreased with an increase in elevation. This variation pattern could be due to the changes in soil temperature and moisture along the elevation gradient. Soil enzyme stoichiometry and resource allocation further revealed that the microbial metabolism activity in the Helan Mountains was limited by carbon (C) and phosphorus (P). Furthermore, the two limited elements were significantly higher at the mid and high altitudes (2,139–2,438 m) than at low altitudes (1,380–1,650 m). Additionally, redundancy analysis revealed that the soil water content and bulk density played a crucial role in microbial community structures, while the soil pH had the most influence on soil EEA and ecoenzymatic stoichiometry. Our findings revealed the patterns of soil microbial community structure, extracellular enzyme activities, and microbial metabolism at various elevations, which will help in understanding the microbial resource limitation and nutrient cycling in mountain ecosystems in arid regions.
Interfacial formation of intermetallic Ni-Al-Ti systems formed by induction heating
Authors: Riyadi Tri Widodo Besar , Siswanto Waluyo Adi , Zhu Xiaomeng 
Published: November 2022

Intermetallic systems of Nickel (Ni), Aluminium (Al), and Titanium (Ti) are candidates for lightweight materials that offer high-temperature resistance. Combustion synthesis has been widely studied to produce intermetallic and coating deposition by exploiting the heat released by the combustion. An underlayer is often used to enhance the adhesion of the coating to the substrate. The interaction of the coating and the underlayer during heating is, therefore, crucial for achieving a good adhesion quality. This work aimed to investigate the microstructure and properties of the interfacial formation across the NiAl coatings and Ti underlayers formed by combustion synthesis. Induction heating was used to initiate the heating and reaction process with heating rates of 46.6, 57.0, and 85.5 K/s. The microstructure was characterized by Scanning Electron Microscopy (SEM) equipped with an Energy Dispersive Spectroscopy (EDS) detector, whereas the formed phases were identified using X-ray Diffraction (XRD) tests. The hardness distribution was measured by the Vickers microhardness test. The result shows that NiAl with Al-rich and Ni-rich were formed in the coating region. The average thickness of the coating increases by approximately 200, 300, and 400 µm with a heating rate of 46.6, 57.0, and 85.5 K/s, respectively. The different thicknesses of the coating can be attributed to the migration of Ni/Al from the coating to the underlayer zones. The microstructure observed in the underlayer confirms the formation of several intermetallic phases of Ni-Ti and Ti-Al systems. The infiltration of Ni and Al elements from Ni and Al to Ti sides was responsible for generating a reaction between Ni-Ai-Ti. The formation of Ti2Ni–Ti3Al phases in the underlayer increases with the heating rate. The hardness across the coating, interface, and underlayer increases with the heating rates. The heating rate of 46.6, 57.0, and 85.5 K/s results in the hardness of the interface by 669.1, 804.8, and 967.7 HV, whereas the underlayer increases by 680.1, 772.7, and 978.7 HV, respectively. The increased content of the Ni-Al-Ti system, which are AlNi2Ti and Ti2Ni–Ti3Al phases, was attributed to the increased hardness of the interface and underlayer. This work improves the understanding of second reactions across the interface while fabricating coatings that apply an underlayer.
Efficacy and safety of COVID-19 inactivated vaccine: A meta-analysis
Authors: Li Xiaoming , Yang Xia , Ning Zong 
Published: November 2022

BackgroundInactivated vaccine is one of the primary technology types of Coronavirus Disease 2019 (COVID-19) vaccines, which has wide application in many countries, including mainland China. However, systematic evaluation of the efficacy and safety of COVID-19 inactivated vaccines remains limited. And trust in the vaccine is the key to solving vaccine hesitancy.MethodsVarious academic databases were searched comprehensively for randomized controlled trials (RCTs) related to COVID-19 inactivated vaccines. The deadline for retrieval was December 2021. Study screening and data extraction were according to inclusive and exclusive criteria. Statistical analyses were performed using RevMan software 5.3 version and STATA software 16.0 version.ResultsEight studies with 79,334 subjects were included of which 48,123 had received two doses of COVID-19 inactivated vaccines, and 31,211 had received two doses of placebo. The results of the meta-analysis showed that: in terms of effectiveness evaluation, two doses of COVID-19 inactivated vaccines decreased the symptomatic infection [relative risk (RR) = 0.23, 95% confidence interval (CI) (0.18,0.30), P &lt; 0.00001], asymptomatic infection [RR = 0.48, 95%CI (0.32, 0.74), P = 0.0008], total infection [RR = 0.32, 95%CI (0.24, 0.41), P &lt; 0.00001] and hospitalization [RR = 0.06, 95%CI (0.01, 0.27), P = 0.0002] for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) significantly. In terms of safety assessment, two doses of COVID-19 inactivated vaccines also caused more adverse events. After two inoculations, total adverse events and systemic adverse events increased significantly [total adverse events RR = 1.14, 95%CI (1.08, 1.21), P &lt; 0.00001; systemic adverse events RR = 1.22, 95%CI (1.09, 1.35), P = 0.0002]. The most common adverse event was pain at the injection site. Almost all local adverse reactions consisted of these events. The incidence of pain at the injection site was related to adjuvants. Using aluminum hydroxide as an adjuvant increased local pain significantly [RR = 1.97, 95%CI (1.52, 2.55), P &lt; 0.00001]. Two doses COVID-19 inactivated vaccines did not increase serious adverse events [RR = 0.71, 95%CI (0.57, 0.90), P = 0.004].ConclusionTwo doses of inactivated COVID-19 vaccines in people over 18 years of age effectively prevented SARS-CoV-2 infection and its associated hospitalizations. Short-term, mild to moderate adverse reactions had occurred, but serious adverse events were rare. No placebo or vaccine-related deaths had been reported.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/, identifier: 42021291250.
Healthy aging and late-life depression in Europe: Does migration matter?
Authors: Marin Ivet Bayes , Fernández Daniel , Ayuso-Mateos Jose Luis , Leonardi Matilde , Tobiasz-Adamczyk Beata , Koskinen Seppo , Sanchez-Niubo Albert , Cristóbal-Narváez Paula 
Published: November 2022

BackgroundThere is limited research examining the impact of risk and protective factors on late-life depression using large population-based datasets, particularly those examining differences among older migrants and non-migrants in Europe countries. Thus, the first aim was to analyze differences between migrants and non-migrants regarding socioeconomic status, depression, multimorbidity, healthy aging, and lifestyle behaviors. The second aim was to examine the impact of healthy aging on late-life depression in older migrants compared to their counterparts without a history of international migration in extensive and harmonized data from different population-based cohort studies.Materials and methodsWe analyzed cross-sectional, predominantly nationally representative, community-based data from European participants in the Aging Trajectories of Health: Longitudinal Opportunities and Synergies (ATHLOS) cohort. The descriptive analyses included sociodemographic variables, somatic comorbidities, multimorbidity, healthy aging, and lifestyle behaviors according to migration status. The effects of these variables on late-life depression were examined in a multivariate logistic regression model, including migration status and years since migration as predictors.ResultsData of 122,571 individuals aged ≥ 50 years were analyzed, of which 11,799 (9.60%) were migrants. The descriptive analyses indicated that compared to non-migrants, migrants showed a higher prevalence of diabetes (25.6%), hypertension (38.0%), coronary artery disease (49.4%), stroke (4.9%), and depression (31.1%). Healthy aging was also better in non-migrants (51.7; SD = 9.7) than in migrants (39.6; SD = 18.2). The results of the logistic regression showed that migration status [OR = 1.231 (CIs: 0.914–1.547)] and increased number of years since migration in the host country [OR = 0.003 (CIs: 0.001–0.005)] were associated with greater levels of depressive symptoms. Concerning health variables, multimorbidity was associated with higher levels of depressive symptoms [OR = 0.244 (CIs: 0.211–0.278)], whereas better healthy aging was associated with fewer depressive symptoms [OR = -0.100 (CIs: -0.102 to -0.098)]. The interaction between migration and healthy aging status was also significant [OR. = -0.019 (CIs: -0.025 to -0.014)].ConclusionMigrants reported higher risks for worse health outcomes compared to non-migrants. Significantly, worse healthy aging was associated with a greater risk of depressive symptoms in migrants than in non-migrants. Shedding light on migration and aging processes is essential for promoting a cross-cultural understanding of late-life depression in Europe.
The brain structure and function abnormalities of migraineurs: A systematic review and neuroimaging meta-analysis
Authors: Chen Zhu-Hong , Cui Yu-Ling , Sun Jing-Ting , Li Yu-Ting , Zhang Chi , Zhang Yang-Ming , Li Ze-Yang , Shang Yu-Xuan , Ni Min-Hua , Hu Bo , Yan Lin-Feng , Wang Wen 
Published: November 2022

ObjectivesTo quantitatively summarize the specific changes in brain structure and function in migraine patients.MethodsA literature screening of migraine was conducted from inception to Sept 1, 2022, in PubMed, Web of Science, Cochrane Library, and Medline databases using the keyword combination of “migraine and MRI.” Activation likelihood estimation (ALE) was performed to assess the differentiation of functional connectivity (FC), regional homogeneity (ReHo), and gray matter volume (GMV) of migraine patients.ResultsEleven voxel-based morphometry (VBM) studies and 25 resting-state fMRI (rs-fMRI) studies (16 FC and 9 ReHo studies) were included in this study. ALE analysis revealed the ReHo increase in the brainstem and left thalamus, with no decreased area. Neither increased nor decreased regions were detected in FC and GMV of migraine patients.ConclusionsThe left thalamus and brainstem were the significantly activated regions of migraine. It is a meaningful insights into the pathophysiology of migraine. The consistent alterated brain areas of morphometrical and functional in migraine patients were far from reached based on current studies.
Case report: Covered stent placement to treat delayed aneurysmal rupture after flow diverter-assisted coil embolization
Authors: Chen Xiheng , Gui Siming , Dong Linggen , Zhang Longhui , Ge Huijian , Liu Peng , Li Youxiang , Lv Ming 
Published: November 2022

IntroductionFlow diverter (FD) placement is widely accepted as a treatment for large saccular intracranial aneurysms. Delayed aneurysmal rupture (DAR) after FD placement is potentially catastrophic and difficult to treat. To our knowledge, using a Willis covered stent (WCS) to treat DAR after placement of a Pipeline Flex embolization device (PFED) combined with coiling has not been previously reported.Case presentationA 49-year-old woman with an incidental asymptomatic large right supraclinoid internal carotid artery aneurysm was treated with PFED placement and adjunctive coiling. DAR causing subarachnoid hemorrhage occurred 11 hours after the procedure. Treatment using a WCS was successful and resulted in a favorable clinical outcome (modified Rankin scale score 2).ConclusionDAR after FD implantation requires isolation of the aneurysm from the cerebral circulation as soon as possible. WCS placement can achieve this immediately and occlude the aneurysm. We hope our case could provide new idea for similar cases in the future.
Clinical and genetic characteristics of Chinese Duchenne/Becker muscular dystrophy patients with small mutations
Authors: Gan Siyi , Liu Shulei , Yang Haiyan , Wu Liwen 
Published: November 2022

BackgroundDuchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are amongst the inherited neuromuscular diseases with the highest incidence. Small mutations are less common and therefore have been poorly studied in China.Materials and methodsThe clinical data of 150 patients diagnosed with DMD/BMD by genetic analysis in Hunan Children’s Hospital from 2009 to 2021 were analyzed. The patients were followed up for an average of 3.42 years and their clinical characteristics were collected. Loss of ambulation (LOA) was used to evaluate the severity of disease progression. The correlation among clinical features, different variants, and glucocorticoid (GC) treatment was analyzed by Cox regression analysis.Results150 different variants were detected in this study, including 21 (14%) novel mutations, 88 (58.7%) non-sense mutations, 33 (22.0%) frameshift mutations, 22 (14.7%) splicing mutations, and 7 (4.7%) missense mutations. Single-exon skipping and single- or double-exon (double/single-exon) skipping strategies covered more than 90% of patients with small mutations. A case with frameshift mutation combined with Klinefelter’s syndrome (47, XXY) and another one with missense mutation combined with epilepsy was found in our study. De novo mutations accounted for 30.0% of all patients. The mean onset age was 4.19 ± 1.63 years old, and the mean diagnosed age was 5.60 ± 3.13 years old. The mean age of LOA was 10.4 years old (40 cases). 60.7% of them received GC treatment at 7.0 ± 2.7 years old. The main causes of complaints were muscle weakness, high creatine kinase (CK), motor retardation, and family history. The risk factors of LOA were positive family history (HR 5.52, CI 1.26–24.18), short GC treatment duration (HR 0.54, CI 0.36–0.82) and frameshift mutation (HR 14.58, CI 1.74–121.76). DMD patients who treated with GC after 7 years old had a higher risk of earlier LOA compared to those receiving treatment before the age of 7 (HR 0.083, CI 0.009–0.804). Moreover, an earlier onset age, a higher CK value, and a larger LOA population were found in the DMD patients compared to the BMD ones. Finally, the locations of the most frequent mutation were in exon 70 and exon 22.ConclusionIn conclusion, 150 small mutations were identified in this study, and 21 of them were discovered for the first time. We found the hotspots of small mutations were in exon 70 and exon 20. Also, the analysis showed that positive family history, frameshift mutation, short duration of GC treatment, and delayed GC treatment resulted in earlier LOA for the DMD patients. Taken together, our findings complement the mutation spectrum of DMD/BMD, benefit us understanding to the DMD disease, and lay foundations for the clinical trials.